🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Charlotte L. Bevan

The London College

ORCID: 0000-0002-7533-0552

Also affiliated with Imperial College London

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic”.

TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic

Research Square(2020)10.21203/rs.3.rs-34503/v1

N/A

0DataRank · unranked

6 citations

A. M. Isac, Charlotte L. Bevan, Greg N. Brooke, Damien A. Leach

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

Nature Communications(2021)10.1038/s41467-021-24342-y

N/A

0DataRank · unranked

91 citations

Andrea Mohr, Efstathios S. Giotis, E. Cil, A. M. Isac, Laura L. Yates +5 more

Faculty Opinions recommendation of Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature(2021)10.3410/f.738340952.793583202

N/A

0DataRank · unranked

0 citations

Theodora A. Constantin, Charlotte L. Bevan

AMPK activation protects against prostate cancer by inducing a catabolic cellular state

Cell Reports(2023)10.1016/j.celrep.2023.112396

N/A

0DataRank · unranked

44 citations

Angela Woods, Alice Pollard, Julia Arizanova, Eneko Pascual-Navarro, Phillip Muckett +13 more